🇺🇸 Dutasteride Capsules in United States
29 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 29
Most-reported reactions
- Asthenia — 4 reports (13.79%)
- Drug Ineffective — 4 reports (13.79%)
- Asthma — 3 reports (10.34%)
- Blood Count Abnormal — 3 reports (10.34%)
- Platelet Count Decreased — 3 reports (10.34%)
- Pneumonia — 3 reports (10.34%)
- Wheezing — 3 reports (10.34%)
- Anaemia — 2 reports (6.9%)
- Atrial Fibrillation — 2 reports (6.9%)
- Brain Injury — 2 reports (6.9%)
Other Urology approved in United States
Frequently asked questions
Is Dutasteride Capsules approved in United States?
Dutasteride Capsules does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Dutasteride Capsules in United States?
UConn Health is the originator. The local marketing authorisation holder may differ — check the official source linked above.